Correlation Between Mirae Asset and INtRON Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mirae Asset and INtRON Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mirae Asset and INtRON Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mirae Asset Daewoo and iNtRON Biotechnology, you can compare the effects of market volatilities on Mirae Asset and INtRON Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mirae Asset with a short position of INtRON Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mirae Asset and INtRON Biotechnology.

Diversification Opportunities for Mirae Asset and INtRON Biotechnology

-0.55
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Mirae and INtRON is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Mirae Asset Daewoo and iNtRON Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iNtRON Biotechnology and Mirae Asset is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mirae Asset Daewoo are associated (or correlated) with INtRON Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iNtRON Biotechnology has no effect on the direction of Mirae Asset i.e., Mirae Asset and INtRON Biotechnology go up and down completely randomly.

Pair Corralation between Mirae Asset and INtRON Biotechnology

Assuming the 90 days trading horizon Mirae Asset Daewoo is expected to generate 3.31 times more return on investment than INtRON Biotechnology. However, Mirae Asset is 3.31 times more volatile than iNtRON Biotechnology. It trades about 0.06 of its potential returns per unit of risk. iNtRON Biotechnology is currently generating about -0.16 per unit of risk. If you would invest  425,500  in Mirae Asset Daewoo on September 1, 2024 and sell it today you would earn a total of  22,500  from holding Mirae Asset Daewoo or generate 5.29% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Mirae Asset Daewoo  vs.  iNtRON Biotechnology

 Performance 
       Timeline  
Mirae Asset Daewoo 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Mirae Asset Daewoo are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Mirae Asset may actually be approaching a critical reversion point that can send shares even higher in December 2024.
iNtRON Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days iNtRON Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Mirae Asset and INtRON Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mirae Asset and INtRON Biotechnology

The main advantage of trading using opposite Mirae Asset and INtRON Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mirae Asset position performs unexpectedly, INtRON Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in INtRON Biotechnology will offset losses from the drop in INtRON Biotechnology's long position.
The idea behind Mirae Asset Daewoo and iNtRON Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Content Syndication
Quickly integrate customizable finance content to your own investment portal